2025年肌少症數位治療藥物全球市場報告

近年來，數位療法治療肌少症的市場規模迅速擴張，從2024年的13.2億美元成長到2025年的15.4億美元，複合年成長率達16.3%。這段歷史時期的成長可歸因於多種因素，例如人口老化加劇、老齡化相關性肌肉萎縮盛行率上升、人們對肌肉減少症的認知不斷提高、遠距遠端醫療服務的普及、家庭復健解決方案需求的不斷成長以及政府推動數位醫療的支持舉措。

預計未來幾年，數位療法治療肌少症市場將快速成長，到2029年將達到27.8億美元，複合年成長率為16.0%。預測期間的成長可歸因於多種因素，例如人口老化、人們對預防性肌肉健康的興趣日益濃厚、人工智慧在數位療法中的整合度不斷提高、數位療法（DTx）報銷政策的擴大、個人化運動計畫的開發、科技公司與醫療服務提供者之間夥伴關係的加強，以及對遠距復健解決方案的需求不斷成長。這段時期的主要趨勢包括：基於人工智慧的個人化運動計畫的進步、與穿戴式健康追蹤器的整合、遠距復健平台的擴展、在老年護理中的應用、遠端患者監護的增強以及數位健康解決方案的創新。

肌少症的數位療法是經過臨床檢驗的、由軟體主導的干涉措施，旨在預防、管理和治療肌少症。肌少症是一種以肌肉質量、力量和功能進行性喪失為特徵的疾病。這些療法基於臨床證據和行為科學，並利用數位平台提供個人化治療策略。

肌少症數位療法的主要產品包括軟體、設備和服務。該軟體透過數位裝置提供客製化的干涉措施，例如運動計劃和營養計劃，以管理肌肉流失並支持復健。這些解決方案透過線上平台、藥局和其他管道銷售，涵蓋肌肉強化、體力活動監測和營養管理等活動。最終使用者包括醫院、診所、家庭護理機構和復健中心。

2025年春季美國突然提高關稅以及由此引發的貿易摩擦對醫療保健產業產生了嚴重影響，特別是對關鍵醫療設備、診斷設備和藥品的供應。醫院和醫療機構面臨進口手術器械、影像設備以及注射器和導管等消耗品成本上漲的問題。這些成本上漲給醫療保健預算帶來了壓力，導致一些醫療機構推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅阻礙了基本藥品和醫療設備的生產，造成了供應鏈瓶頸。作為應對措施，該行業正在籌資策略多樣化，盡可能促進本地生產，並倡導對緊急醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供數位治療肌少症市場統計數據，例如全球市場規模、區域佔有率、競爭對手在數位治療肌少症市場的佔有率、詳細的數位治療肌少症細分市場、市場趨勢和商業機會。本數位治療肌少症市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

合併症盛行率的上升預計將推動肌少症數位療法市場的未來成長。合併症是指兩種或兩種以上健康狀況同時存在於一個人身上。隨著人口老化，由於生理功能下降和長期暴露於健康風險中，罹患多種慢性疾病的風險增加。肌少症的數位療法透過促進規律運動和肌肉強化、改善新陳代謝和減少脂肪堆積，可有效預防併發症，尤其是肥胖。例如，總部位於英國的會員組織世界肥胖聯合會在 2024 年 3 月報告稱，到 2035 年，預計約 79% 的超重和肥胖成年人居住在中低收入國家，肥胖成年人總數預計將達到 15.3 億。因此，併發症的上升支持了肌少症數位療法市場的成長。

肌少症數位療法市場的關鍵公司正專注於開發先進的解決方案，例如藥物發現平台，以開發更有針對性的治療方法，提高治療效果，並加速與老齡化相關的肌肉損失的個人化治療。藥物發現平台透過使用先進的工具和方法，可以更快、更有效地識別和開發藥物。例如，2025 年 4 月，以色列生物技術公司 ProFuse Technology 宣布了一個藥物發現平台，旨在預防因 GLP-1減重藥、老化（肌少症）和癌症惡病質引起的肌肉損失。透過使用實驗室培育的、模仿天然肌肉的高度成熟的肌肉組織，該公司可以更準確、更有效地測試和篩檢候選藥物。這個創新平台減少了對動物測試的依賴並降低了研究成本。隨著對肌肉保存治療方法的需求不斷成長，ProFuse 正在將其業務從培養肉擴展到生物製藥，提供一種開創性的方法來解決日益嚴重的肌肉健康挑戰。

2023年8月，美國製藥公司禮來公司以19億美元收購了Versanis Bio。此次收購擴大了禮來的產品組合，Versanis的主導產品比麥格魯單抗目前正在進行單獨或與Semaglutide聯合治療超重或肥胖患者的2b期臨床試驗。 Versanis Bio是一家總部位於美國的製藥公司，專注於開發治療肌少症的藥物，此次收購將增強禮來在肥胖和肌肉減少治療領域的實力。

數位療法肌少症市場由提供軟體主導治療性介入、預測分析整合和復健交付等服務的營業單位所獲得的收益所構成。市場價值還包括服務供應商銷售或包含在其服務產品中的相關產品的價值。數位療法肌少症市場還包括穿戴式裝置、生物感測器以及虛擬和擴增實境工具的銷售。該市場的價值是指“出廠價”，即產品製造商或創造者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球數位治療肌少症：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球數位治療肌少症市場：成長率分析
• 全球數位治療肌少症市場表現：規模與成長，2019-2024 年
• 全球數位治療肌少症市場預測：規模與成長，2024-2029 年，2034 年
• 全球肌少症數位療法：總潛在市場（TAM）

第6章 市場細分

• 全球數位治療肌少症市場：按產品、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 軟體
• 裝置
• 服務
• 全球數位治療藥物肌少症市場：按分銷管道、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 線上平台
• 藥局
• 其他分銷管道
• 全球數位治療肌少症市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 肌肉強化
• 體力活動監測
• 營養管理
• 其他用途
• 全球數位治療肌少症市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院和診所
• 居家照護環境
• 復健中心
• 其他最終用戶
• 全球數位治療肌少症市場：按軟體（類型）、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
• 行動應用程式
• 網路為基礎的平台
• 人工智慧監控工具
• 運動和復健計劃
• 營養指導軟體
• 全球數位治療肌少症市場：按設備（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 穿戴式健身追蹤器
• 智慧秤
• 連接阻力帶
• 肌電圖（EMG）設備
• 肌力評估工具
• 全球數位治療肌少症市場：按服務類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
• 遠端患者監護服務
• 虛擬物理治療課程
• 遠距會診服務
• 個人化輔導服務
• 數據分析和報告服務

第7章 區域和國家分析

• 全球數位治療肌少症市場：區域表現與預測，2019-2024 年、2024-2029 年、2034 年
• 全球數位治療肌少症市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 數位治療肌少症市場：競爭格局
• 數位治療肌少症市場：公司簡介
  • Noom Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sword Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Biofourmis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Hinge Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Omada Health Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Virta Health Corp.
• Evolv Rehabilitation Technologies Ltd.
• Click Therapeutics Inc.
• DarioHealth Corp.
• WellDoc Inc.
• Propeller Health
• Lark Technologies Inc.
• mySugr GmbH
• SilverCloud Health Limited（a part of Amwell）
• Kaia Health Software GmbH
• Liva Healthcare A/S
• Zibrio Inc.
• Gait Up SA
• Noraxon Inc.
• Mira Rehab Limited

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029 年數位治療肌少症市場：提供新機會的國家
• 2029 年肌少症數位治療市場：細分領域帶來新機會
• 2029 年肌少症數位治療藥物市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Digital therapeutics for sarcopenia refer to clinically validated, software-driven interventions designed to prevent, manage, or treat sarcopenia, a condition marked by progressive loss of muscle mass, strength, and functionality. These interventions utilize digital platforms to deliver personalized treatment strategies based on clinical evidence and behavioral science.

The primary products of digital therapeutics for sarcopenia include software, devices, and services. The software delivers tailored interventions such as exercise programs and nutrition plans via digital devices to help users manage muscle loss and support recovery. These solutions are distributed through online platforms, pharmacies, and other channels, with applications including muscle strengthening, physical activity monitoring, and nutrition management. End users include hospitals, clinics, homecare settings, rehabilitation centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The digital therapeutics sarcopenia market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics sarcopenia market statistics, including the digital therapeutics sarcopenia industry global market size, regional shares, competitors with the digital therapeutics sarcopenia market share, detailed digital therapeutics sarcopenia market segments, market trends, and opportunities, and any further data you may need to thrive in the digital therapeutics sarcopenia industry. This digital therapeutics sarcopenia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The digital therapeutics sarcopenia market size has grown rapidly in recent years. It will grow from $1.32 billion in 2024 to $1.54 billion in 2025 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to the increasing aging population, rising prevalence of age-related muscle loss, growing awareness of sarcopenia, expanding adoption of telehealth services, rising demand for home-based rehabilitation solutions, and supportive government initiatives promoting digital healthcare.

The digital therapeutics sarcopenia market size is expected to see rapid growth in the next few years. It will grow to $2.78 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to the rising aging population, increasing focus on preventive muscle health, growing integration of AI in digital therapeutics, expanding reimbursement policies for digital therapeutics (DTx), development of personalized exercise programs, strengthening partnerships between technology firms and healthcare providers, and rising demand for remote rehabilitation solutions. Major trends during this period include advancements in AI-driven personalized exercise programs, integration with wearable health trackers, expansion of tele-rehabilitation platforms, adoption in elderly care, enhanced remote patient monitoring, and innovations in digital health solutions.

The rising prevalence of comorbidities is expected to drive the growth of the digital therapeutics sarcopenia market going forward. Comorbidities refer to the coexistence of two or more health conditions in a single individual. The increase in comorbidities is primarily driven by the aging population, as advancing age raises the risk of developing multiple chronic conditions due to declining physiological functions and prolonged exposure to health risks. Digital therapeutics for sarcopenia are effective in preventing comorbidities, particularly obesity, by encouraging regular physical activity and muscle strengthening, which improve metabolism and reduce fat accumulation. For example, in March 2024, the World Obesity Federation, a UK-based membership organization, reported that nearly 79% of adults affected by overweight and obesity are projected to reside in low- and middle-income nations by 2035, with the total number of adults with obesity expected to reach 1.53 billion. Therefore, the rising prevalence of comorbidities is supporting the growth of the digital therapeutics sarcopenia market.

Key companies in the digital therapeutics sarcopenia market are focusing on developing advanced solutions, such as drug discovery platforms, to create more targeted therapies, improve treatment efficacy, and accelerate personalized care for age-related muscle loss. A drug discovery platform enables faster and more efficient identification and development of new drugs using advanced tools and methods. For instance, in April 2025, ProFuse Technology, an Israel-based biotechnology company, introduced a drug discovery platform aimed at preventing muscle loss caused by GLP-1 weight-loss drugs, aging (sarcopenia), and cancer cachexia. By using lab-grown, highly mature muscle tissues that replicate natural muscle, the company can test and screen drug candidates more accurately and efficiently. This innovative platform reduces dependency on animal testing and lowers research costs. With rising demand for muscle-preserving therapies, ProFuse is expanding from cultivated meat into biopharma, offering a pioneering approach to tackle growing muscle health challenges.

In August 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired Versanis Bio for $1.9 billion. This acquisition expanded Lilly's portfolio to include Versanis' main asset, bimagrumab, which is currently being evaluated in Phase 2b trials both alone and in combination with semaglutide for individuals with overweight or obesity. Versanis Bio, a US-based pharmaceutical company, specializes in developing therapies for sarcopenia, and this acquisition strengthens Eli Lilly's presence in treatments targeting obesity and muscle loss.

Major players in the digital therapeutics sarcopenia market are Noom Inc., Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Virta Health Corp., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Propeller Health, Lark Technologies Inc., mySugr GmbH, SilverCloud Health Limited (a part of Amwell), Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, and Cometa Srl.

North America was the largest region in the digital therapeutics sarcopenia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital therapeutics sarcopenia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the digital therapeutics sarcopenia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics sarcopenia market consists of revenues earned by entities by providing services such as software-driven therapeutic interventions, integration of predictive analytics, and delivery of rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics sarcopenia market also includes sales of wearable devices, biosensors, and virtual and augmented reality tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Sarcopenia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics sarcopenia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics sarcopenia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics sarcopenia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Software; Devices; Services
• 2) By Distribution Channel: Online Platforms; Pharmacies; Other Distribution Channels
• 3) By Application: Muscle Strengthening; Physical Activity Monitoring; Nutrition Management; Other Applications
• 4) By End User: Hospitals And Clinics; Homecare Settings; Rehabilitation Centers; Other End Users
• Subsegments:
• 1) By Software: Mobile Applications; Web-Based Platforms; AI-Powered Monitoring Tools; Exercise And Rehabilitation Programs; Nutritional Guidance Software
• 2) By Devices: Wearable Fitness Trackers; Smart Scales; Connected Resistance Bands; Electromyography (EMG) Devices; Muscle Strength Assessment Tools
• 3) By Services: Remote Patient Monitoring Services; Virtual Physiotherapy Sessions; Teleconsultation Services; Personalized Coaching Services; Data Analytics And Reporting Services
• Companies Mentioned: Noom Inc.; Sword Health Inc.; Biofourmis Inc.; Hinge Health Inc.; Omada Health Inc.; Virta Health Corp.; Evolv Rehabilitation Technologies Ltd.; Click Therapeutics Inc.; DarioHealth Corp.; WellDoc Inc.; Propeller Health; Lark Technologies Inc.; mySugr GmbH; SilverCloud Health Limited (a part of Amwell); Kaia Health Software GmbH; Liva Healthcare A/S; Zibrio Inc.; Gait Up SA; Noraxon Inc.; Mira Rehab Limited; Cometa Srl.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Therapeutics Sarcopenia Market Characteristics

3. Digital Therapeutics Sarcopenia Market Trends And Strategies

4. Digital Therapeutics Sarcopenia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics Sarcopenia Growth Analysis And Strategic Analysis Framework

• 5.1. Global Digital Therapeutics Sarcopenia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Digital Therapeutics Sarcopenia Market Growth Rate Analysis
• 5.4. Global Digital Therapeutics Sarcopenia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Digital Therapeutics Sarcopenia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Digital Therapeutics Sarcopenia Total Addressable Market (TAM)

6. Digital Therapeutics Sarcopenia Market Segmentation

• 6.1. Global Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Devices
• Services
• 6.2. Global Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Platforms
• Pharmacies
• Other Distribution Channels
• 6.3. Global Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Muscle Strengthening
• Physical Activity Monitoring
• Nutrition Management
• Other Applications
• 6.4. Global Digital Therapeutics Sarcopenia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Homecare Settings
• Rehabilitation Centers
• Other End Users
• 6.5. Global Digital Therapeutics Sarcopenia Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mobile Applications
• Web-Based Platforms
• AI-Powered Monitoring Tools
• Exercise And Rehabilitation Programs
• Nutritional Guidance Software
• 6.6. Global Digital Therapeutics Sarcopenia Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wearable Fitness Trackers
• Smart Scales
• Connected Resistance Bands
• Electromyography (EMG) Devices
• Muscle Strength Assessment Tools
• 6.7. Global Digital Therapeutics Sarcopenia Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Remote Patient Monitoring Services
• Virtual Physiotherapy Sessions
• Teleconsultation Services
• Personalized Coaching Services
• Data Analytics And Reporting Services

7. Digital Therapeutics Sarcopenia Market Regional And Country Analysis

• 7.1. Global Digital Therapeutics Sarcopenia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Digital Therapeutics Sarcopenia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics Sarcopenia Market

• 8.1. Asia-Pacific Digital Therapeutics Sarcopenia Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics Sarcopenia Market

• 9.1. China Digital Therapeutics Sarcopenia Market Overview
• 9.2. China Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics Sarcopenia Market

• 10.1. India Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics Sarcopenia Market

• 11.1. Japan Digital Therapeutics Sarcopenia Market Overview
• 11.2. Japan Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics Sarcopenia Market

• 12.1. Australia Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics Sarcopenia Market

• 13.1. Indonesia Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics Sarcopenia Market

• 14.1. South Korea Digital Therapeutics Sarcopenia Market Overview
• 14.2. South Korea Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics Sarcopenia Market

• 15.1. Western Europe Digital Therapeutics Sarcopenia Market Overview
• 15.2. Western Europe Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics Sarcopenia Market

• 16.1. UK Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics Sarcopenia Market

• 17.1. Germany Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics Sarcopenia Market

• 18.1. France Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics Sarcopenia Market

• 19.1. Italy Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics Sarcopenia Market

• 20.1. Spain Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics Sarcopenia Market

• 21.1. Eastern Europe Digital Therapeutics Sarcopenia Market Overview
• 21.2. Eastern Europe Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics Sarcopenia Market

• 22.1. Russia Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics Sarcopenia Market

• 23.1. North America Digital Therapeutics Sarcopenia Market Overview
• 23.2. North America Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics Sarcopenia Market

• 24.1. USA Digital Therapeutics Sarcopenia Market Overview
• 24.2. USA Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics Sarcopenia Market

• 25.1. Canada Digital Therapeutics Sarcopenia Market Overview
• 25.2. Canada Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics Sarcopenia Market

• 26.1. South America Digital Therapeutics Sarcopenia Market Overview
• 26.2. South America Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics Sarcopenia Market

• 27.1. Brazil Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics Sarcopenia Market

• 28.1. Middle East Digital Therapeutics Sarcopenia Market Overview
• 28.2. Middle East Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics Sarcopenia Market

• 29.1. Africa Digital Therapeutics Sarcopenia Market Overview
• 29.2. Africa Digital Therapeutics Sarcopenia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Digital Therapeutics Sarcopenia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Digital Therapeutics Sarcopenia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics Sarcopenia Market Competitive Landscape And Company Profiles

• 30.1. Digital Therapeutics Sarcopenia Market Competitive Landscape
• 30.2. Digital Therapeutics Sarcopenia Market Company Profiles
  • 30.2.1. Noom Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sword Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Biofourmis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Hinge Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Omada Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics Sarcopenia Market Other Major And Innovative Companies

• 31.1. Virta Health Corp.
• 31.2. Evolv Rehabilitation Technologies Ltd.
• 31.3. Click Therapeutics Inc.
• 31.4. DarioHealth Corp.
• 31.5. WellDoc Inc.
• 31.6. Propeller Health
• 31.7. Lark Technologies Inc.
• 31.8. mySugr GmbH
• 31.9. SilverCloud Health Limited (a part of Amwell)
• 31.10. Kaia Health Software GmbH
• 31.11. Liva Healthcare A/S
• 31.12. Zibrio Inc.
• 31.13. Gait Up SA
• 31.14. Noraxon Inc.
• 31.15. Mira Rehab Limited

32. Global Digital Therapeutics Sarcopenia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics Sarcopenia Market

34. Recent Developments In The Digital Therapeutics Sarcopenia Market

35. Digital Therapeutics Sarcopenia Market High Potential Countries, Segments and Strategies

• 35.1 Digital Therapeutics Sarcopenia Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Digital Therapeutics Sarcopenia Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Digital Therapeutics Sarcopenia Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer